Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

Merck & Co. said Tuesday it is pausing shipments to ... sales in China emerged six months ago when Merck announced the first initial drop in sales. At the time, Merck executives said a number ...

Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...

Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that ... New negotiated prices for that first round of drugs go into effect ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the ...

On Tuesday (February 4), Amgen (NASDAQ:AMGN), Merck (NYSE:MRK ... increase in product sales was primarily by the pharmaceutical company's strong performance in oncology and immunology therapies ...

My most recent article was written on June 10, titled “Dividends And Innovation: Why Merck Is A ... pause to China. At first sight, the numbers weren't half bad, as the company generated 7% ...

Stocks rebounded after a wild day for global markets, with big tech leading the way. The dollar halted a six-day advance.